156 related articles for article (PubMed ID: 31209059)
1. Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation.
Wang Y; Tan X; Tang Y; Zhang C; Xu J; Zhou J; Cheng X; Hou N; Liu W; Yang G; Teng Y; Yang X
Cancer Res; 2019 Sep; 79(17):4466-4479. PubMed ID: 31209059
[TBL] [Abstract][Full Text] [Related]
2. Combined Mutation of
Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
[TBL] [Abstract][Full Text] [Related]
3. BMP7 Signaling in
Eikesdal HP; Becker LM; Teng Y; Kizu A; Carstens JL; Kanasaki K; Sugimoto H; LeBleu VS; Kalluri R
Mol Cancer Res; 2018 Oct; 16(10):1568-1578. PubMed ID: 29934328
[TBL] [Abstract][Full Text] [Related]
4. Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer.
Mukhopadhyay A; Berrett KC; Kc U; Clair PM; Pop SM; Carr SR; Witt BL; Oliver TG
Cell Rep; 2014 Jul; 8(1):40-9. PubMed ID: 24953650
[TBL] [Abstract][Full Text] [Related]
5. Sex-Determining Region Y-box 2 Promotes Growth of Lung Squamous Cell Carcinoma and Directly Targets Cyclin D1.
Li C; He B; Huang C; Yang H; Cao L; Huang J; Hu C
DNA Cell Biol; 2017 Apr; 36(4):264-272. PubMed ID: 28151013
[TBL] [Abstract][Full Text] [Related]
6. Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma.
Chiou J; Su CY; Jan YH; Yang CJ; Huang MS; Yu YL; Hsiao M
Sci Rep; 2017 Aug; 7(1):9830. PubMed ID: 28852126
[TBL] [Abstract][Full Text] [Related]
7. SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.
Fukazawa T; Guo M; Ishida N; Yamatsuji T; Takaoka M; Yokota E; Haisa M; Miyake N; Ikeda T; Okui T; Takigawa N; Maeda Y; Naomoto Y
Sci Rep; 2016 Feb; 6():20113. PubMed ID: 26846300
[TBL] [Abstract][Full Text] [Related]
8. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma.
Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ
Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565
[TBL] [Abstract][Full Text] [Related]
9. Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation.
Tan X; Tong L; Li L; Xu J; Xie S; Ji L; Fu J; Liu Q; Shen S; Liu Y; Xiao Y; Gao F; Moses RE; Bardeesy N; Wang Y; Zhang J; Tang L; Li L; Wong KK; Song D; Yang X; Liu J; Li X
Nat Commun; 2021 Aug; 12(1):4853. PubMed ID: 34381046
[TBL] [Abstract][Full Text] [Related]
10. SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis.
Hussenet T; du Manoir S
Cell Cycle; 2010 Apr; 9(8):1480-6. PubMed ID: 20372069
[TBL] [Abstract][Full Text] [Related]
11. Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.
Brcic L; Sherer CK; Shuai Y; Hornick JL; Chirieac LR; Dacic S
Am J Clin Pathol; 2012 Nov; 138(5):712-8. PubMed ID: 23086772
[TBL] [Abstract][Full Text] [Related]
12. Epithelial stem cell mutations that promote squamous cell carcinoma metastasis.
White RA; Neiman JM; Reddi A; Han G; Birlea S; Mitra D; Dionne L; Fernandez P; Murao K; Bian L; Keysar SB; Goldstein NB; Song N; Bornstein S; Han Z; Lu X; Wisell J; Li F; Song J; Lu SL; Jimeno A; Roop DR; Wang XJ
J Clin Invest; 2013 Oct; 123(10):4390-404. PubMed ID: 23999427
[TBL] [Abstract][Full Text] [Related]
13. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
14. Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma.
Dong Z; Guo W; Guo Y; Kuang G; Yang Z
Am J Med Sci; 2012 May; 343(5):375-81. PubMed ID: 22314103
[TBL] [Abstract][Full Text] [Related]
15. Role of PTEN in basal cell derived lung carcinogenesis.
Malkoski SP; Cleaver TG; Thompson JJ; Sutton WP; Haeger SM; Rodriguez KJ; Lu SL; Merrick D; Wang XJ
Mol Carcinog; 2014 Oct; 53(10):841-6. PubMed ID: 23625632
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase (iNOS)-activated Cxcr2 signaling in myeloid cells promotes TGFβ-dependent squamous cell carcinoma lung metastasis.
Li X; Ke Y; Hernandez AL; Yu J; Bian L; Hall SC; Nolan K; Wang JH; Young CD; Wang XJ
Cancer Lett; 2023 Aug; 570():216330. PubMed ID: 37524225
[TBL] [Abstract][Full Text] [Related]
17. CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.
Hur JY; Kim HR; Lee JY; Park S; Hwang JA; Kim WS; Yoon S; Choi CM; Rho JK; Lee JC
Cell Oncol (Dordr); 2019 Aug; 42(4):449-458. PubMed ID: 30838525
[TBL] [Abstract][Full Text] [Related]
18. A Transforming Growth Factor-β and H19 Signaling Axis in Tumor-Initiating Hepatocytes That Regulates Hepatic Carcinogenesis.
Zhang J; Han C; Ungerleider N; Chen W; Song K; Wang Y; Kwon H; Ma W; Wu T
Hepatology; 2019 Apr; 69(4):1549-1563. PubMed ID: 30014520
[TBL] [Abstract][Full Text] [Related]
19. A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA.
Zhou Y; Sinha S; Schwartz JL; Adami GR
BMC Cancer; 2019 Jun; 19(1):607. PubMed ID: 31221127
[TBL] [Abstract][Full Text] [Related]
20. SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.
Watanabe H; Ma Q; Peng S; Adelmant G; Swain D; Song W; Fox C; Francis JM; Pedamallu CS; DeLuca DS; Brooks AN; Wang S; Que J; Rustgi AK; Wong KK; Ligon KL; Liu XS; Marto JA; Meyerson M; Bass AJ
J Clin Invest; 2014 Apr; 124(4):1636-45. PubMed ID: 24590290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
